deferiprone has been researched along with Postoperative Complications in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, T | 1 |
White, A | 1 |
Meades, K | 1 |
Bala, C | 1 |
Efthimia, V | 1 |
Neokleous, N | 1 |
Agapidou, A | 1 |
Economou, M | 1 |
Vetsiou, E | 1 |
Teli, A | 1 |
Perifanis, V | 1 |
2 other studies available for deferiprone and Postoperative Complications
Article | Year |
---|---|
Novel topical therapy for corneal blood staining.
Topics: Aged; Blood; Cornea; Corneal Diseases; Deferiprone; Humans; Iron Chelating Agents; Male; Ophthalmic | 2017 |
Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience.
Topics: Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Child; Child, Preschool; Deferasirox; Deferip | 2013 |